Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. - LEAD CASE
1:15-cv-13099
Overview
Parties
Defendant
Collegium Pharmaceutical, Inc. - LEAD CASE Operating Company
Represented By
0 Attorneys ListedPlaintiff
Purdue Pharma, L.P. NPE (University / Research)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Massachusetts (mad)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10407434
Process for preparing oxycodone compositions
|
Filed: 2019-01-30
Issued: 2019-09-10
|
Active (12.2 yrs remaining)
Expires: 2039-01-30
|
|
|
US9693961
Pharmaceutical formulation containing gelling agent
|
Filed: 2016-02-04
Issued: 2017-07-04
|
Active (9.2 yrs remaining)
Expires: 2036-02-04
|
|
|
US9522919
Oxycodone compositions
|
Filed: 2015-05-29
Issued: 2016-12-20
|
Active (8.5 yrs remaining)
Expires: 2035-05-29
|
|
|
US9073933
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
|
Filed: 2012-02-06
Issued: 2015-07-07
|
Expired (Term Ended)
Expires: 2026-02-11
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
21
Dispositive
8
Granted
0
Denied
0
Pending / Review
21
Motions by Category
Key Dispositive Motions & Rulings